Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morton Coleman

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Cancer|August 26, 2006
Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?Morton Coleman, Lale Kostakoglu
Oncology (Williston Park, N.Y.)|March 15, 2014
POEMS syndrome: what's in a name?Adriana C Rossi, Morton Coleman
Acta Haematologica|October 28, 2015
It's Time to Take Clarithromycin Seriously in Multiple MyelomaTomer M Mark, Morton Coleman
Oncology (Williston Park, N.Y.)|June 4, 2010
Best practices in the management of newly diagnosed multiple myeloma patients who will not undergo transplantRuben Niesvizky, Morton Coleman, Tomer Mark
Cancer|November 26, 2008
Novel agents in myeloma: an exciting sagaTomer Mark, Ruben Niesvizky, Morton Coleman
American Journal of Ophthalmology|October 18, 2005
Periocular mucosa-associated lymphoid/low grade lymphomas: treatment with antibioticsDavid H Abramson, Indira Rollins, Morton Coleman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Progress in mantle-cell lymphomaPeter Martin, Morton Coleman, John P Leonard
Oncology (Williston Park, N.Y.)|August 29, 2009
Management of relapsed mantle cell lymphoma: still a treatment challengeJia Ruan, Morton Coleman, John P Leonard
Leukemia Research|April 3, 2014
Preclinical and clinical results with pomalidomide in the treatment of relapsed/refractory multiple myelomaTomer M Mark, Morton Coleman, Ruben Niesvizky
International Journal of Cancer|March 25, 2006
Proteasome inhibition with bortezomib: a new therapeutic strategy for non-Hodgkin's lymphomaJohn P Leonard, Richard R Furman, Morton Coleman
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Cancer|August 26, 2006
Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?Morton Coleman, Lale Kostakoglu
Oncology (Williston Park, N.Y.)|March 15, 2014
POEMS syndrome: what's in a name?Adriana C Rossi, Morton Coleman
Acta Haematologica|October 28, 2015
It's Time to Take Clarithromycin Seriously in Multiple MyelomaTomer M Mark, Morton Coleman
Oncology (Williston Park, N.Y.)|June 4, 2010
Best practices in the management of newly diagnosed multiple myeloma patients who will not undergo transplantRuben Niesvizky, Morton Coleman, Tomer Mark
Cancer|November 26, 2008
Novel agents in myeloma: an exciting sagaTomer Mark, Ruben Niesvizky, Morton Coleman
American Journal of Ophthalmology|October 18, 2005
Periocular mucosa-associated lymphoid/low grade lymphomas: treatment with antibioticsDavid H Abramson, Indira Rollins, Morton Coleman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Progress in mantle-cell lymphomaPeter Martin, Morton Coleman, John P Leonard
Oncology (Williston Park, N.Y.)|August 29, 2009
Management of relapsed mantle cell lymphoma: still a treatment challengeJia Ruan, Morton Coleman, John P Leonard
Leukemia Research|April 3, 2014
Preclinical and clinical results with pomalidomide in the treatment of relapsed/refractory multiple myelomaTomer M Mark, Morton Coleman, Ruben Niesvizky
International Journal of Cancer|March 25, 2006
Proteasome inhibition with bortezomib: a new therapeutic strategy for non-Hodgkin's lymphomaJohn P Leonard, Richard R Furman, Morton Coleman
Pageof 12